The weekly litigation news digest is live. Subscribe now

IP Verse

Injectable Gels Comprising Cross-Linked Hyaluronic Acid And Hydroxyapatite, And Methods Of Manufacturing Thereof - EP3509559

The patent EP3509559 was granted to Allergan Pharmaceuticals on Jul 19, 2023. The application was filed on Sep 7, 2017 under application number EP17848293A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3509559

ALLERGAN PHARMACEUTICALS
Application Number
EP17848293A
Filing Date
Sep 7, 2017
Status
Granted And Under Opposition
May 5, 2023
Publication Date
Jul 19, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MERZ PHARMAMar 7, 2024WALLINGER RICKER SCHLOTTER TOSTMANNADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2015257989
OPPOSITIONCN101596328
OPPOSITIONUS2015238525
OPPOSITIONUS2015257989
OPPOSITIONWO2012028620
OPPOSITIONWO2013053457
OPPOSITIONWO2016074794
OPPOSITIONWO2017045084
SEARCHUS2015238525
SEARCHWO2013053457
SEARCHWO2016074794
SEARCHWO2017045084

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents